JP2007518817A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007518817A5 JP2007518817A5 JP2006551345A JP2006551345A JP2007518817A5 JP 2007518817 A5 JP2007518817 A5 JP 2007518817A5 JP 2006551345 A JP2006551345 A JP 2006551345A JP 2006551345 A JP2006551345 A JP 2006551345A JP 2007518817 A5 JP2007518817 A5 JP 2007518817A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mometasone furoate
- corticosteroid
- mometasone
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 30
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 claims 12
- 229960002744 mometasone furoate Drugs 0.000 claims 10
- 239000003246 corticosteroid Substances 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 229960002714 fluticasone Drugs 0.000 claims 4
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 claims 4
- 239000007921 spray Substances 0.000 claims 4
- 229960005294 triamcinolone Drugs 0.000 claims 4
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 3
- 206010001076 Acute sinusitis Diseases 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 229940088710 antibiotic agent Drugs 0.000 claims 2
- 239000007900 aqueous suspension Substances 0.000 claims 2
- 229960000289 fluticasone propionate Drugs 0.000 claims 2
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 claims 2
- 229960001664 mometasone Drugs 0.000 claims 2
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 claims 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims 1
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 229940092705 beclomethasone Drugs 0.000 claims 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 claims 1
- 229960004436 budesonide Drugs 0.000 claims 1
- -1 butoxycanto Chemical compound 0.000 claims 1
- 229960003728 ciclesonide Drugs 0.000 claims 1
- 229960001145 deflazacort Drugs 0.000 claims 1
- FBHSPRKOSMHSIF-GRMWVWQJSA-N deflazacort Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)=N[C@@]3(C(=O)COC(=O)C)[C@@]1(C)C[C@@H]2O FBHSPRKOSMHSIF-GRMWVWQJSA-N 0.000 claims 1
- 229960003957 dexamethasone Drugs 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- GWVOFXBLSFFSEG-UHFFFAOYSA-N furan-2-carboxylic acid;hydrate Chemical compound O.OC(=O)C1=CC=CO1 GWVOFXBLSFFSEG-UHFFFAOYSA-N 0.000 claims 1
- 229960001798 loteprednol Drugs 0.000 claims 1
- YPZVAYHNBBHPTO-MXRBDKCISA-N loteprednol Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)OCCl)[C@@H]4[C@@H]3CCC2=C1 YPZVAYHNBBHPTO-MXRBDKCISA-N 0.000 claims 1
- IXTCZMJQGGONPY-XJAYAHQCSA-N rofleponide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O IXTCZMJQGGONPY-XJAYAHQCSA-N 0.000 claims 1
- 229950004432 rofleponide Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53783004P | 2004-01-21 | 2004-01-21 | |
| US60/537,830 | 2004-01-21 | ||
| PCT/US2005/002105 WO2005072704A2 (en) | 2004-01-21 | 2005-01-19 | Method of treating acute rhinosinusitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008016970A Division JP2008110991A (ja) | 2004-01-21 | 2008-01-28 | 処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007518817A JP2007518817A (ja) | 2007-07-12 |
| JP2007518817A5 true JP2007518817A5 (https=) | 2008-03-13 |
| JP4976139B2 JP4976139B2 (ja) | 2012-07-18 |
Family
ID=34825945
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006551345A Expired - Fee Related JP4976139B2 (ja) | 2004-01-21 | 2005-01-19 | 処置方法 |
| JP2008016970A Pending JP2008110991A (ja) | 2004-01-21 | 2008-01-28 | 処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008016970A Pending JP2008110991A (ja) | 2004-01-21 | 2008-01-28 | 処置方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050186144A1 (https=) |
| EP (2) | EP1711164B1 (https=) |
| JP (2) | JP4976139B2 (https=) |
| AT (1) | ATE461693T1 (https=) |
| CA (1) | CA2554064A1 (https=) |
| CY (1) | CY1110620T1 (https=) |
| DE (1) | DE602005020113D1 (https=) |
| DK (1) | DK1711164T3 (https=) |
| ES (2) | ES2340777T3 (https=) |
| HR (1) | HRP20100208T8 (https=) |
| MX (1) | MXPA06008240A (https=) |
| PL (1) | PL1711164T3 (https=) |
| PT (1) | PT1711164E (https=) |
| RS (1) | RS51335B (https=) |
| SI (1) | SI1711164T1 (https=) |
| WO (1) | WO2005072704A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005020113D1 (de) * | 2004-01-21 | 2010-05-06 | Schering Corp | Verfahren zur behandlung von akuten rhinosinusitis |
| US20090325917A1 (en) * | 2006-10-19 | 2009-12-31 | Cipla Limited | Pharmaceutical Compositions and Nasal Spray Incorporating Anhydrous Mometasone Furoate |
| RU2407558C1 (ru) * | 2009-07-02 | 2010-12-27 | Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава") | Способ лечения острого риносинусита у детей |
| TWI411121B (zh) * | 2010-03-11 | 2013-10-01 | Ind Tech Res Inst | 光吸收層之製造方法及應用其之太陽能電池結構 |
| WO2014106021A1 (en) | 2012-12-27 | 2014-07-03 | Massachusetts Eye & Ear Infirmary | Treatment of rhinosinusitis with p-glycoprotein inhibitors |
| WO2017123933A1 (en) | 2016-01-15 | 2017-07-20 | Massachusetts Eye And Ear Infirmary | Secreted p-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis |
| US12295933B2 (en) | 2019-03-25 | 2025-05-13 | Massachusetts Eye And Ear Infirmary | Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity |
| IL299210A (en) * | 2020-06-21 | 2023-02-01 | Massachusetts Eye & Ear Infirmary | Combined treatment of verapamil and methotrexate for the treatment of chronic rhinosinusitis |
| JP2024049405A (ja) * | 2021-02-22 | 2024-04-10 | 興和株式会社 | 新規吸入剤 |
| EP4566595A1 (en) * | 2023-12-07 | 2025-06-11 | Bernhard Roth | Combination preparation for the treatment of acute and chronic rhinosinusitis |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE8790T1 (de) | 1981-02-02 | 1984-08-15 | Schering Corporation | Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. |
| US4731447A (en) * | 1985-05-13 | 1988-03-15 | Schering Corporation | Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof |
| US4873335A (en) * | 1986-03-12 | 1989-10-10 | Schering Corporation | 3-phenethyl-2-benzene-amides or aza-derivatives thereof |
| ZA924164B (en) | 1991-06-10 | 1993-02-24 | Schering Corp | Non-chlorofluorocarbon aerosol formulations |
| HUT67445A (en) * | 1991-06-10 | 1995-04-28 | Schering Corp | Aerosol formulations containing 1,1,1,2-tetrafluorethane |
| US6127353A (en) * | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| US5837699A (en) | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| US6068832A (en) | 1996-08-29 | 2000-05-30 | Schering Corporation | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| US5837713A (en) * | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
| US6503537B2 (en) * | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
| US6495167B2 (en) * | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
| US6187765B1 (en) | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
| US6297227B1 (en) * | 1998-09-10 | 2001-10-02 | Schering Corporation | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
| SE9803770D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Dry powder pharmaceutical formulation |
| US6465581B1 (en) * | 2001-01-24 | 2002-10-15 | The Goodyear Tire & Rubber Company | Silica reinforced rubber composition which contains stabilized unsymmetrical coupling agents and article of manufacture, including a tire, having at least one component comprised of such rubber composition |
| TWI324934B (en) * | 2001-08-28 | 2010-05-21 | Schering Corp | Pharmaceutical compositions for the treatment of asthma |
| WO2004018025A1 (en) * | 2002-08-23 | 2004-03-04 | Schering Corporation | Pharmaceutical compositions |
| US20040081625A1 (en) * | 2002-10-21 | 2004-04-29 | Schering Corporation | Nasal formulations for the treatment of allergies |
| US8912174B2 (en) * | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
| KR20060106823A (ko) * | 2003-10-20 | 2006-10-12 | 쉐링 코포레이션 | 약제학적 에어로졸 조성물 |
| DE602005020113D1 (de) * | 2004-01-21 | 2010-05-06 | Schering Corp | Verfahren zur behandlung von akuten rhinosinusitis |
| CN103429296A (zh) | 2010-12-13 | 2013-12-04 | 内诺斯蒂姆股份有限公司 | 递送导管系统和方法 |
| US9106249B1 (en) | 2014-09-04 | 2015-08-11 | Semtech Corporation | Calibration of a time-interleaved analog-to-digital converter |
-
2005
- 2005-01-19 DE DE602005020113T patent/DE602005020113D1/de not_active Expired - Lifetime
- 2005-01-19 AT AT05711867T patent/ATE461693T1/de active
- 2005-01-19 WO PCT/US2005/002105 patent/WO2005072704A2/en not_active Ceased
- 2005-01-19 US US11/038,343 patent/US20050186144A1/en not_active Abandoned
- 2005-01-19 HR HR20100208T patent/HRP20100208T8/xx unknown
- 2005-01-19 CA CA002554064A patent/CA2554064A1/en not_active Abandoned
- 2005-01-19 EP EP05711867A patent/EP1711164B1/en not_active Expired - Lifetime
- 2005-01-19 EP EP10003076.6A patent/EP2201936B1/en not_active Revoked
- 2005-01-19 PL PL05711867T patent/PL1711164T3/pl unknown
- 2005-01-19 ES ES05711867T patent/ES2340777T3/es not_active Expired - Lifetime
- 2005-01-19 JP JP2006551345A patent/JP4976139B2/ja not_active Expired - Fee Related
- 2005-01-19 RS RSP-2010/0236A patent/RS51335B/sr unknown
- 2005-01-19 ES ES10003076T patent/ES2426957T3/es not_active Expired - Lifetime
- 2005-01-19 DK DK05711867.1T patent/DK1711164T3/da active
- 2005-01-19 PT PT05711867T patent/PT1711164E/pt unknown
- 2005-01-19 MX MXPA06008240A patent/MXPA06008240A/es active IP Right Grant
- 2005-01-19 SI SI200531000T patent/SI1711164T1/sl unknown
-
2008
- 2008-01-28 JP JP2008016970A patent/JP2008110991A/ja active Pending
- 2008-07-11 US US12/171,989 patent/US20090022671A1/en not_active Abandoned
-
2010
- 2010-04-28 CY CY20101100378T patent/CY1110620T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007520508A5 (https=) | ||
| JP2004514739A5 (https=) | ||
| JP6762931B2 (ja) | 経鼻組成物と該経鼻組成物の使用方法の改善 | |
| JP2016510012A5 (https=) | ||
| HRP20151214T1 (hr) | Pripravak za inhalaciju koji sadrži aklidinij za lijeäśenje kroniäśne opstruktivne pluä†ne bolesti | |
| RU2011135824A (ru) | Применение глюкокортикоидной композиции для лечения тяжелой и неконтролируемой астмы | |
| CN103052378A (zh) | 包含磷酸二酯酶抑制剂的药物制剂 | |
| HRP20100104T1 (hr) | Kombinacije koje sadrže antimuskarinska sredstva i kortikosteroide | |
| RU2011101151A (ru) | Интраназальные композиции, содержащие деконгестант и кортикостероид | |
| JP2015519356A5 (https=) | ||
| NZ600789A (en) | Aerosol formulation for copd | |
| JP2007518817A5 (https=) | ||
| JP2016510012A (ja) | Ｍａｂａ化合物およびコルチコステロイドを含む組合せ剤 | |
| US20090022671A1 (en) | Treatment methods | |
| JP2016527245A (ja) | Ｍａｂａ化合物およびコルチコステロイドを含む組合せ剤 | |
| HRP20140818T1 (hr) | Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata | |
| US10383883B2 (en) | Treatment of congestion using steroids and adrenergics | |
| JP2011500731A5 (https=) | ||
| JP2008525317A5 (https=) | ||
| CA2456721C (en) | Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders | |
| WO2007046113A3 (en) | Novel pharmaceutical composition comprising alkaloid and process thereof | |
| RU2013144043A (ru) | Фармацевтическая композиция для применения назальным введением, содержащая кортикостероид и хинолон или фузидовую кислоту | |
| WO2018069830A1 (en) | Pharmaceutical composition for the treatment of sinusitis and COPD | |
| HK40091740A (zh) | 用於治疗、改善或预防微生物感染的制造产品和方法 | |
| CN104274482A (zh) | 治疗哮喘的药物 |